ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism

24 Apr 2024 08:30:00 By Nasdaq GlobeNewswire

Ascendis Pharma to Participate in the Leerink Partners Global Biopharma Conference 2024

04 Mar 2024 08:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

26 Feb 2024 09:56:01 By NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

23 Feb 2024 09:59:55 By NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

22 Feb 2024 09:46:07 By NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

21 Feb 2024 13:40:15 By NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

20 Feb 2024 09:47:47 By NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

16 Feb 2024 10:32:49 By NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

15 Feb 2024 10:16:52 By NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

14 Feb 2024 12:58:28 By NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

13 Feb 2024 11:23:43 By NetDania Notify

Ascendis Pharma Reports Fourth Quarter and Full Year 2023 Results

07 Feb 2024 16:01:00 By Nasdaq GlobeNewswire

Ascendis Pharma to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

07 Feb 2024 08:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

06 Feb 2024 10:02:47 By NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

02 Feb 2024 09:47:26 By NetDania Notify

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

01 Feb 2024 15:32:36 By NetDania Notify

Ascendis Pharma to Report Full Year 2023 Financial Results and Provide Business Update on February 7, 2024

31 Jan 2024 16:15:00 By Nasdaq GlobeNewswire

Ascendis Pharma Launches 2nd TransCon™ Product: YORVIPATH® Now Available in Germany and Austria for Adults with Chronic Hypoparathyroidism

31 Jan 2024 16:01:00 By Nasdaq GlobeNewswire

New Company Eyconis Formed to Develop Ascendis Pharma Ophthalmology Assets with $150 Million Commitment from External Investors

29 Jan 2024 08:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: ASCENDIS PHARMA A/S - AMERICAN DEPOSITARY SHARES

09 Jan 2024 09:49:31 By NetDania Notify